Cell Therapy

From Research to Clinical Trials to Commercialization: Advancing CGT with Frozen Cellular Starting Materials

Dominic Mancini

OrganaBio

Developability

Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments

Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.

Coriolis Pharma

Advanced Therapies

Ensuring Nuclease Free Process Consumables for Biopharma Applications

Richard Fry

Sanisure

Bbiotherapeutics

Protein Science and the Future of Biotherapeutics

Mathias Uhlén, Ph.D.

NorthX Biologics

Biomanufacturing

Enabling Digital Twins With Computational Fluid Dynamics Modeling

Sangmin Paik, Ph.D.

Samsung Biologics

Pharma

Impact of Strategic Location on Supply Chain Efficiency

Steven Uebele

Frontier Scientific Solutions

Gene

Synthetic DNA Delivers a Sustainable Future for Genetic Medicines

Touchlight

RNA

Screening T7 Polymerases to Optimize xRNA Yield and Quality

Jing Zhu, Ph.D.

ReciBioPharm

Foreign Trade

Economic and Environmental Benefits of Utilizing a Foreign Trade Zone

Michael Braddock II

Frontier Scientific Solutions

Large Molecule

Managing Pharmacovigilance Challenges for Biosimilars

Ivana Lisec, MPharm

PrimeVigilance

Sustainability

Tackling Plastic Waste: The Elephant in the Room of Pharma’s Sustainability Drive

Sophie Lutter, Ph.D.

Pharma's Almanac

CDMO

Navigating the Complexities of Microbial and Mammalian Manufacturing

Peter Boman; Helena Pettersson

NorthX Biologics

CDMO

The Improvements of the Production and Stability of a mAb-Chelator Conjugate by Modified Transchelation Conditions

Hyung-il Lee, Ph.D.

GBI

Nonviral Delivery

Rewriting the Rules of Gene Therapy with Nonviral DNA Delivery using dbDNA

Lisa Caproni

Touchlight

AI

AI Implementation to Enhance Quality

Seongil Cho; Hyeokgeon Kwon; Kisung Shim

Samsung Biologics

Autoimmune Diseases

Why Autoimmune Diseases Are Taking Center Stage: Rising Prevalence, Breakthroughs, and Market Opportunities

Chia Chia Sun; Gardiner Smith

Fab Biopharma

CDMO

Advancing the Science of Technical and Therapeutic Proteins

Eva-Karin Gidlund, Ph.D.

NorthX Biologics

Virotherapy

Oncolytic Virotherapy: Real Potential and Difficult Challenges

Cynthia A. Challener, Ph.D.

Pharma's Almanac

AAV Quality

Improving AAV Vector Quality with In-Process Monitoring of Capsid Formation

Nathan Sweeney, Ph.D.; Hena Divanovic, M.Sc.

Rentschler Biopharma SE

PPQ

Fast Path to Market: Going from GMP1 to PPQ in Just 12 Months

Jessica Feldman, Ph.D.; Henning Gerschewski

Rentschler Biopharma SE